1. Enzyme flexibility, solvent and weak interactions characterize thrombin–ligand interactions: implications for drug design Richard A Engh, Hans Brandstetter, Gudrun Sucher, Andreas Eichinger, Ulrich Baumann, Wolfram Bode, Robert Huber, Thomas Poll, Rainer Rudolph, Wolfgang von der Saal Structure Volume 4, Issue 11, Pages 1353-1362 (November 1996) DOI: 10.1016/S0969-2126(96)00142-6

2. Figure 1 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

3. Figure 2 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

4. Figure 3 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

5. Figure 4 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

6. Figure 5 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

7. Figure 6 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)

8. Figure 7 Structure 1996 4, 1353-1362DOI: (10.1016/S0969-2126(96)00142-6)